ACF Bioservices

Home>>ACF Bioservices

Using Empty AAV Capsids to Reduce Inhibitory Effect of Neutralizing Antibodies on AAV Transduction

Using Empty AAV Capsids to Reduce Inhibitory Effect of Neutralizing Antibodies on AAV Transduction Jiu Jiang, PhD1, Steven Wright, PhD2, and Ismael Hidalgo, PhD1 1Absorption Systems LLC, 436 [...]

2019-11-13T09:54:15-05:00November 13, 2019|Categories: ACF Bioservices|Tags: , , |

Gene Therapy in Combination: A Promising Avenue for Cancer Treatment

Gene therapies (GTs) are a rapidly growing field of cancer treatment, with almost 2000 active clinical trials worldwide representing 65% of total gene therapies. There is particular [...]

2019-10-04T15:39:34-05:00October 4, 2019|Categories: AbsorbThis Blog, ACF Bioservices|Tags: , |

Webinar: Challenges in Adapting Neutralizing and Anti-Drug Antibody Assays to Gene Therapies

Webinar Download Originally Hosted: Thursday, October 10, 2019 11:00am - 12:00pm EDT Challenges in Adapting Neutralizing and Anti-Drug Antibody Assays to Gene Therapies This presentation summarizes a [...]

2019-10-14T14:15:39-05:00September 17, 2019|Categories: ACF Bioservices, Bioanalysis, Webinars|Tags: , |

NAbbed Again: Challenges in Developing Neutralizing and Anti-drug Antibody Assays for Gene Therapy

Abstract Gene Therapy is one of the most recent and fast-growing fields of medicine, which promises to change the way we approach and treat different diseases, including [...]

2019-09-17T13:40:26-05:00September 17, 2019|Categories: ACF Bioservices|Tags: , |

Demand Exceeds Supply in Cell & Gene Therapy Workforce

The recent rapid growth of cell and gene therapies (CGTs) has led to a gap in the talent market that represents both a challenge and opportunity for [...]

2019-09-17T10:18:27-05:00September 16, 2019|Categories: AbsorbThis Blog, ACF Bioservices|Tags: , |